These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1504 related articles for article (PubMed ID: 25283627)

  • 1. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor status.
    Hvidtfeldt UA; Tjønneland A; Keiding N; Lange T; Andersen I; Sørensen TI; Prescott E; Hansen ÅM; Grønbæk M; Bojesen SE; Diderichsen F; Rod NH
    Epidemiology; 2015 May; 26(3):353-61. PubMed ID: 25695354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
    Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
    Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy and breast cancer: what factors modify the association?
    Gertig DM; Fletcher AS; English DR; Macinnis RJ; Hopper JL; Giles GG
    Menopause; 2006; 13(2):178-84. PubMed ID: 16645531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort profile: the Social Inequality in Cancer (SIC) cohort study.
    Nordahl H; Hvidtfeldt UA; Diderichsen F; Rod NH; Osler M; Frederiksen BL; Prescott E; Tjønneland A; Lange T; Keiding N; Andersen PK; Andersen I
    Int J Epidemiol; 2014 Dec; 43(6):1750-8. PubMed ID: 24550248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer.
    Modugno F; Kip KE; Cochrane B; Kuller L; Klug TL; Rohan TE; Chlebowski RT; Lasser N; Stefanick ML
    Int J Cancer; 2006 Mar; 118(5):1292-301. PubMed ID: 16161054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up to one-third of breast cancer cases in post-menopausal Mediterranean women might be avoided by modifying lifestyle habits: the EPIC Italy study.
    Masala G; Bendinelli B; Assedi M; Occhini D; Zanna I; Sieri S; Agnoli C; Sacerdote C; Ricceri F; Mattiello A; Panico S; Tumino R; Frasca G; Saieva C; Palli D
    Breast Cancer Res Treat; 2017 Jan; 161(2):311-320. PubMed ID: 27832394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
    Li CI; Malone KE; Daling JR
    Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
    Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
    Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol consumption and breast cancer risk in the Women's Health Study.
    Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
    Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer.
    Hvidtfeldt UA; Gunter MJ; Lange T; Chlebowski RT; Lane D; Farhat GN; Freiberg MS; Keiding N; Lee JS; Prentice R; Tjønneland A; Vitolins MZ; Wassertheil-Smoller S; Strickler HD; Rod NH
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1203-12. PubMed ID: 22564867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of metabolic indicators, smoking, alcohol and socioeconomic position on mortality after breast cancer.
    Larsen SB; Kroman N; Ibfelt EH; Christensen J; Tjønneland A; Dalton SO
    Acta Oncol; 2015 May; 54(5):780-8. PubMed ID: 25761087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
    Tamimi RM; Spiegelman D; Smith-Warner SA; Wang M; Pazaris M; Willett WC; Eliassen AH; Hunter DJ
    Am J Epidemiol; 2016 Dec; 184(12):884-893. PubMed ID: 27923781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.